Skip to main content
Vai all'homepage della Commissione europea (si apre in una nuova finestra)
italiano it
CORDIS - Risultati della ricerca dell’UE
CORDIS

Innovative risk assessment for individualizing treatment in chronic lymphocytic leukemia

Obiettivo

Chronic lymphocytic leukemia faces high-challenging and timely problems related to the classification and efficient prognosis of patients at the time of diagnosis and the attempt to personalize the treatment. CLLassify addresses these issues in a pioneering fashion within a multidisciplinary collaboration, proposing an improved classification of the patients, based on innovative statistical techniques as well as the novel aspect of personalized prediction of the need for treatment at a specific time point for the individual patient. The statistical background of the applicant, together with the expertise of his supervisor in CLL, guarantee the successful implementation of this project. This will result both in significant health advances and societal benefits for the European society at large raising the project at the level of a European priority, and to significant improvement of the applicant’s career prospects within Europe.

Campo scientifico (EuroSciVoc)

Programma(i)

Argomento(i)

Meccanismo di finanziamento

MSCA-IF-EF-ST - Standard EF

Vedi tutti i progetti finanziati nell’ambito di questo schema di finanziamento

Invito a presentare proposte

(si apre in una nuova finestra) H2020-MSCA-IF-2015

Vedi tutti i progetti finanziati nell’ambito del bando

Coordinatore

ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS
Contributo netto dell'UE
€ 164 653,20
Indirizzo
CHARILAOU THERMI ROAD 6 KM
570 01 THERMI THESSALONIKI
Grecia
Regione
Βόρεια Ελλάδα Κεντρική Μακεδονία Θεσσαλονίκη
Tipo di attività
Research Organisations
Collegamenti
Costo totale
€ 164 653,20